Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction

Cardiology in the Young

Volumn 22, Issue 3, 2012, Pages 349-352

  Natterer, Julia ^a   Perez, Marie Hélène ^a   Di Bernardo, Stefano ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

intensive care; Key wordsShock; vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALTEPLASE; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CATECHOLAMINE; CORTICOSTEROID; HEMOGLOBIN; IMIPENEM; IMMUNOGLOBULIN; VANCOMYCIN;

ABDOMINAL PAIN; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; BRAIN HEMORRHAGE; CAPILLARY LEAK SYNDROME; CARDIOMEGALY; CASE REPORT; CHILD; CHILD DEATH; CLINICAL ARTICLE; COLLOID; CONJUNCTIVITIS; CORONARY ARTERY ANEURYSM; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FEVER; HEART MUSCLE BIOPSY; HEART TAMPONADE; HUMAN; HUMAN TISSUE; HYPOTENSION; INTRACRANIAL HYPERTENSION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUROLOGIC DISEASE; PEDIATRIC INTENSIVE CARE UNIT; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PLEURA EFFUSION; PRESCHOOL CHILD; RASH; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SEPTIC SHOCK; SHOCK; SORE THROAT; SUPERIOR CAVA VEIN OBSTRUCTION; THORAX RADIOGRAPHY; TOXIC SHOCK SYNDROME; DIFFERENTIAL DIAGNOSIS; INTENSIVE CARE UNIT;

CAPILLARY LEAK SYNDROME; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PLEURAL EFFUSION; SHOCK, SEPTIC;

EID: 84866774330     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951111001314     Document Type: Article

References (10)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771.
2. Cha S, Yoon M, Ahn Y, Han M, Yoon KL. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci 2008; 23: 718-722.
3. Gamillscheg A, Zobel G, Karpf EF, et al. Atypical presentation of Kawasaki disease in an infant. Pediatr Cardiol 1993; 14: 223-226.
4. Hamada H, Terai M, Honda T, Kohno Y. Marked pleural and pericardial effusion with elevated Vascular Endothelial Growth Factor production: an uncommon complication of Kawasaki disease. Pediatr Int 2005; 47: 112-114.
5. Sittiwangkul R, Pongprot Y. Large pleural effusion: an unusual manifestation of Kawasaki disease. Clin Pediatr (Phila) 2004; 43: 389-391.
6. Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30: 681-694.
7. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003; 108: 325-330.
8. Yasukawa K, Terai M, Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002; 105: 766-769.
9. Wiesenthal AM, Todd JK. Toxic shock syndrome in children aged 10 years or less. Pediatrics 1984; 74: 112-117.
10. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glode MP. Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 2008; 122: e786-e790.